Department of Neurology, Centro Hospitalar Universitário de São João, EPE, Porto, Portugal.
Department of Clinic Neurosciences and Mental Health, Medical Faculty of Porto University, Porto, Portugal.
J Thromb Thrombolysis. 2020 Nov;50(4):984-988. doi: 10.1007/s11239-020-02072-0.
Central retinal artery occlusion (CRAO) is a neuro-ophthalmological emergency. There is a finite time window for acute interventions such as revascularization (e.g. intravenous thrombolysis-IVT) and retinal oxygenation (e.g. hyperbaric oxygen therapy-HBOT) therapies. Case 1: A 35-year-old female presented with CRAO in the right eye (OD) confirmed by fluorescein angiography (FA) and optical coherence tomography (OCT). She underwent 4 sessions of HBOT (100% O2 at 2.4 atmosphere absolute for 90 min). Afterwards, visual defect on the nasal field was kept but visual acuity (VA) improved from counting fingers to 1.0. Case 2: A 65-year-old male presented with CRAO in his left eye (OS) with 1.5 h of evolution. Orbital sonography and OCT confirmed the presence of an embolus and he underwent IVT with rTPA (0.9 mg/kg). VA improved from light perception to 0.1. Case 3: A 21-year-old male presented acute visual loss in his OD with 2.5 h of evolution. OCT and retinography identified CRAO. He was submitted to IVT (rTPA-0.9 mg/kg) followed by 12 sessions of HBOT. VA improved from hand motion to 1.0. Our case series depicts the approaches and possible outcomes in acute management of an infrequent, but highly morbid, cerebroretinovascular disorder. Future clinical trials are warranted to tackle current difficulties in CRAO treatment.
视网膜中央动脉阻塞(CRAO)是一种神经眼科急症。急性干预(如血管再通治疗[例如,静脉内溶栓治疗-IVT]和视网膜氧合治疗[例如,高压氧治疗-HBOT])有一个有限的时间窗。
病例 1:一名 35 岁女性因右眼 CRAO 就诊,经荧光素血管造影(FA)和光学相干断层扫描(OCT)确诊。她接受了 4 次 HBOT(2.4 个绝对大气压下 100%氧气,每次 90 分钟)。此后,鼻侧视野的视觉缺陷仍存在,但视力(VA)从指数提高到 1.0。
病例 2:一名 65 岁男性因左眼 CRAO 就诊,发病时间为 1.5 小时。眼眶超声和 OCT 证实存在栓子,他接受了 rTPA(0.9mg/kg)的 IVT。VA 从光感提高到 0.1。
病例 3:一名 21 岁男性因右眼急性视力丧失就诊,发病时间为 2.5 小时。OCT 和视网膜摄影术确定了 CRAO。他接受了 IVT(rTPA-0.9mg/kg),随后进行了 12 次 HBOT。VA 从手动提高到 1.0。
本病例系列描述了急性处理罕见但高度病态的脑视网膜血管疾病的方法和可能的结果。需要进行未来的临床试验来解决 CRAO 治疗中的当前困难。